Skip to main content
Have a personal or library account? Click to login
Eruptive Sebaceous Hyperplasia as a Side Effect of Oral Tacrolimus in a Renal Transplant Recipient – A Case Report Cover

Eruptive Sebaceous Hyperplasia as a Side Effect of Oral Tacrolimus in a Renal Transplant Recipient – A Case Report

Open Access
|Aug 2026

References

  1. Farci F, Rapini RP. Sebaceous hyperplasia. In: Stat-Pearls. Treasure Island (FL): StatPearls Publishing; 2025.
  2. Kanada KN, Merin MR, Munden A, Friedlander SF. A prospective study of cutaneous findings in newborns in the United States: correlation with race, ethnicity, and gestational status using updated classification and nomenclature. J Pediatr. 2012;161(2):240-5.
  3. Steinmetz CZ, Getz A, Schaffer A, Richardson SK. Eruptive sebaceous hyperplasia: a case report and review of the literature. HCA Healthc J Med. 2023;4(4): 315-9.
  4. Robles DT, Ume A, Horneck NC, Ranes J. Sebaceous hyperplasia: background, pathophysiology, etiology [Internet]. 2025 [cited 2026 Apr 8]. Available from: https://emedicine.medscape.com/article/1059368-overview#a7
  5. Al-Daraji WI, Wagner B, Ali RB, McDonagh AJ. Sebaceous hyperplasia of the vulva: a clinicopathological case report with a review of the literature. J Clin Pathol. 2007;60(7):835-7.
  6. Caytemel C, Demir FT, Uzuner EG, Turkoglu Z. Systemic isotretinoin treatment in a renal transplant patient developing sebaceous hyperplasia due to cyclosporine. North Clin Istanb. 2020;7(6):628-30.
  7. Wilken R, Fung MA, Shi VY, Cheng MY, Patel F, Sultani H, et al. Cyclosporine-induced sebaceous hyper-plasia in a hematopoetic stem cell transplant patient: delayed onset of a common adverse event. Dermatol Online J. 2016;22(1):13030/qt4865202s.
  8. Cortés B, Kaya G. Multiple eruptive sebaceous hyper-plasia secondary to cyclosporin in a patient with bone marrow transplantation. Dermatopathology (Basel). 2016;3(4):79-82.
  9. Levandoski KA, Girardi NA, Loss MJ. Eruptive sebaceous hyperplasia as a side effect of oral tacrolimus in a renal transplant recipient. Dermatol Online J. 2017;23(5):13030/qt7x0125gz.
  10. Jung HY, Kim M, Cho BK, Park HJ. A case of cyclosporine-induced sebaceous hyperplasia in a renal transplant patient successfully treated with isotretinoin. Ann Dermatol. 2016;28(2):271-2.
  11. Ranasinghe GC, Friedman AJ. Eruptive sebaceous hyperplasia: a rare consequence of systemic corticosteroids. J Drugs Dermatol. 2018;17(1):118-20.
  12. Mikkelsen CS, Penningua L, Gunnars-Son GL, Abus-land TB. Eruptive sebaceous hyperplasia: an uncommon side effect of systemic corticosteroid use in a renal transplant patient. Forum for Nordic Dermato-Venereology. 2019;24(1):1-2.
  13. Hussein L, Perrett CM. Treatment of sebaceous gland hyperplasia: a review of the literature. J Dermatolog Treat. 2021;32(8):866-77.
  14. Woźniak B, Sauer N, Pogorzelska-Antkowiak A, Dzięgiel P, Calik J. Treatment of sebaceous hyperplasia by high-frequency focused ultrasound (HIFU): a comprehensive exploration with clinical insights. J Clin Med. 2025;14(4):1305.
DOI: https://doi.org/10.2478/sjdv-2026-0003 | Journal eISSN: 2406-0631 | Journal ISSN: 1821-0902
Language: English
Page range: 19 - 25
Submitted on: Feb 10, 2026
Accepted on: Apr 16, 2026
Published on: Aug 10, 2026
Published by: Serbian Association of Dermatovenereologists (SAD)
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2026 Emilija Stefanović, Suzana Makragić, Slađana Cekić, Andrija Jović, Danijela Popović, Nataša Vidović, Zorana Zlatanović, Tanja Mladenović, Anita Mehmedović, Danica Tiodorović, published by Serbian Association of Dermatovenereologists (SAD)
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.